Abstract:OBJECTIVE: To develop the simultaneous determination method of irbesartan and hydrochlorothiazide in human plasma, and to evaluate the bioequivalence of 2 kinds of Irbesartan hydrochlorothiazide tablets. METHODS: Telmisartan was used as the internal standard. Plasma sample was extracted with acetonitrile and centrifuged. LC-MS/MS method was adopted and the determination was performed on Waters XTerra RP18(150 mm×4.6 mm,5 μm)column with acetonitrile-1 mmol·L-1 ammonium acetate buffer solution (pH adjusted to 9.0 using ammonia water)(35∶65) as mobile phase. Mass charge ratio of ion pair irbesartan was m/z -427.3→-193.0 and that of hydrochlorothiazide was m/z -296.0→-122.9. The bioequivalence of test preparation and reference preparation of Irbesartan hydrochlorothiazide tablets in 18 healthy volunteers after oral administration were investigated in randomized double-cycle cross-over design. RESULTS: The linear ranges were 2.00～5 000 μg·L-1 for irbesartan(r=0.998 4)and 2.00～200 μg·L-1 for hydrochlorothiazide (r=0.998 8). The lowest limits of quantization were 2.00 μg ·L-1. The recovery rate was above 90%, and the intra-day and inter-day RSDs were both less than 10%. The recoveries of irbesartan ranged 96.3%～108.0%, and that of hydrochlorothiazide ranged 98.2%～100.5%. There were no significant difference in cmax, AUC0～t, AUC0～∞ between two preparation and cycles (P0.05). There was no significant differenc in tmax between two preparations in non-parameter test (P0.05). CONCLUSION: The method is simple in pretreatment and is specific, rapid, and accurate in analysis. The method can simultaneously determine plasma concentration of irbesartan and hydrochlorothiazide quantitatively. Two preparations are bioequivalent.

Determination of lisinopril in human plasma by HPLC-MS:application to bioequivalence study

Development and Validation of LC-MS Method for the Determination of Lisinopril in Human Plasma and Its Application in a Bioequivalence Study.

HPLC-MS/MS Determination of Lisinopril Tablets in Human Plasma

Bioequivalence Assessment of Two Lisinopril Tablets in Healthy Volunteers

Simultaneous Determination of Enalapril and Enalaprilat in Human Plasma by LC-MS: Application to a Bioequivalence Study

Improved LC-MS Method in Pretreatment for the Determination of Lisinopril in Human Plasma and Its Application

Determination of Amlodipine Concentration in Human Plasma by LC-MS/MS Method and Bioequivalence Study of Its Tablets

Determination of amlodipine in human plasma by LC-MS and study on its bioequivalence

Rapid Quantification of Lisinopril in Human Plasma by Liquid Chromatography/tandem Mass Spectrometry

Determination of Huperzine A in Human Plasma by LC-MS/MS and Its Application to Relative Bioavailability of Huperzine A Tablets

Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of lisinopril in human plasma.

Determination of Enalapril and Enalaprilat in Human Plasma by HPLC-MS

Rapid determination of losartan in human plasma by LC-MS/MS and study on its bioequivalence

Determination of Telmisartan in Human Plasma by LC-MS/MS and Bioequivalence Study of It

Determination of Prazosin Hydrochloride in Human Plasma by HPLC-MS: Application to Its Bioequivalance

Determination of losartan and its metabolite in human plasma by LC-MS/MS and bioequi valence study of losartan potassium tablets

Simultaneous Determination of Plasma Concentrations of 2 Components of Lrbesartan Hydrochlorothiazide Tablet and Bioequivalence Study of It

Study of Pharmacokinetics and Bioequivalence of Telmisartan in Human Plasma by HPLC-MS Method

Determination of Irbesartan and Hydrochlorothiazide in Human Plasma and Bioequivalence Assessment of the Compound Tablets by Capillary-HPLC

Determination of Enalapril in Human Plasma with HPLC- MS

Study on the Bioequivalence of Rabeprazole Enteric- Coated Tablets in Human Plasma